{"id":"NCT01270828","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia","officialTitle":"A Phase 3 Double-blind, Randomized, Placebo-controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia (Protocol A0081224)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-03","primaryCompletion":"2014-09","completion":"2014-11","firstPosted":"2011-01-05","resultsPosted":"2016-01-13","lastUpdate":"2021-01-28"},"enrollment":806,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Post Herpetic Neuralgia"],"interventions":[{"type":"DRUG","name":"Pregabalin","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Pregablain CR tablet 82.5 to 660mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to explore the safety and efficacy of a new once a day pregabalin formulation versus placebo for patients with post herpetic neuralgia (Shingles)","primaryOutcome":{"measure":"Number of Participants With Loss of Therapeutic Response.","timeFrame":"13 Weeks","effectByArm":[{"arm":"Pregabalin CR DB","deltaMin":29,"sd":null},{"arm":"Placebo DB","deltaMin":63,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":146,"countries":["United States","Bulgaria","Colombia","Croatia","Czechia","Denmark","Germany","Hong Kong","India","Poland","Russia","Serbia","Slovakia","South Africa","Sweden","Taiwan","Ukraine"]},"refs":{"pmids":["27753650"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081224&StudyName=Safety%20And%20Efficacy%20Study%20Of%20Once%20Daily%20Controlled%20Release%20Pregabalin%20In%20The%20Treatment%20Of%20Patients%20With%20Postherpetic%20Neuralgia%20"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":208},"commonTop":["Dizziness","Somnolence"]}}